Autologous Fibroblast Grafts in Facial Skin Regeneration

Federal University of São Paulo20 enrolled

Overview

The purpose of this study is to evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.

\- Analytical prospective autocontrolled study

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Skin Aging

Interventions

autologous fibroblasts graftsPROCEDURE

Autologous cultured fibroblasts will be grafted in facial skin

Eligibility

Sex: FEMALEMin age: 50 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women, aged between 50 to 70 years with facial wrinkles (rhytides), * Fitzpatrick III skin type, and * Who had reached menopause at least 3 years before entering the study were eligible for participation. Exclusion Criteria: * Women with uncontrolled comorbid conditions, * Smokers, * Alcohol and corticosteroid users, * Who had undergone chemical peeling or skin filling in the face or neck at least 12 months prior to the study, * Who had a keloid scar, * Who scored below 18 on the Mini-Mental State Examination, * Who had any psychiatric disorder or those undergoing orthodontic treatment were excluded from the study.

Outcomes

Primary Outcomes

Regeneration of facial ectoderm

To evaluate the presence of skin changes after grafting of autologous fibroblasts by means of biophysical, histological, immunohistological, gene expression, glycosaminoglycan, and sensitivity analyses.

Time frame: one year after the grafting of autologous fibroblasts.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.